Onset and Progression of Atrophic Age-Related Macular Degeneration: Toxic byproducts of Vision
Sirion Therapeutics provides an overview of the physiologic progression of AMD and the strategies it is pursuing to retard retinal pigment epithelium (RPE) damage. For more information see www.SirionTherapeutics.com.
1,947 views since 6/23/2008
Comments (0)